Allergan, Inc.  

(Public, NYSE:AGN)   Watch this stock  
Find more results for AGN
97.73
-0.81 (-0.82%)
May 22 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 97.46 - 99.33
52 week 81.28 - 116.45
Open 98.52
Vol / Avg. 2.80M/2.38M
Mkt cap 28.97B
P/E 26.14
Div/yield 0.05/0.20
EPS 3.74
Shares 296.40M
Beta 0.84
Inst. own 92%
May 14, 2013
Allergan at Bank of America Merrill Lynch Health Care Conference
May 1, 2013
Q1 2013 Allergan Earnings Conference Call
Apr 30, 2013
Allergan Annual Shareholder Meeting
Mar 5, 2013
Allergan at Cowen Health Care Conference
Feb 26, 2013
Allergan at Citi Global Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '13) 2012
Net profit margin 18.70% 19.49%
Operating margin 25.42% 28.53%
EBITD margin - 30.89%
Return on average assets 11.88% 12.45%
Return on average equity 19.46% 19.68%
Employees 11,100 -
Carbon Disclosure Rating - 90/100

Address

2525 Dupont Drive
IRVINE, CA 92612
United States - Map
+1-714-2464500 (Phone)
+1-714-2466987 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
About Company - Wikipedia
Discussion Group - Google Finance

Description

Allergan, Inc., is a multi-specialty health care company focused on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products. The Company operates in two segments: specialty pharmaceuticals and medical devices. On June 17, 2011, it acquired Alacer Biomedical, Inc. (Alacer). On August 8, 2011, it acquired Precision Light, Inc. (Precision Light). On July 22, 2011, it acquired Vicept Therapeutics, Inc. (Vicept). During the year ended December, 31, 2011, it discontinued its EasyBand Remote Adjustable Gastric Band System. In February 2011, it discontinued the United States sales of Zymar. In December 2012, the Company acquired SkinMedica, Inc. Effective March 1, 2013, Allergen Inc acquired the entire share capital of MAP Pharmaceuticals Inc. Effective March 1, 2013, Allergen Inc acquired the entire share capital of MAP Pharmaceuticals Inc.

Officers and directors

David E. I. Pyott Chairman of the Board, President, Chief Executive Officer, Principal Executive Officer
Age: 59
Bio & Compensation  - Reuters
Jeffrey L. Edwards Chief Financial Officer, Principal Financial Officer, Executive Vice President - Finance and Business Development
Age: 52
Bio & Compensation  - Reuters
Scott M. Whitcup M.D. Executive Vice President - Research & Development, Chief Scientific Officer
Age: 53
Bio & Compensation  - Reuters
Arnold A. Pinkston Executive Vice President, General Counsel, Assistant Secretary
Age: 54
Bio & Compensation  - Reuters
Scott D. Sherman Executive Vice President - Human Resources
Age: 47
Bio & Compensation  - Reuters
Raymond H. Diradoorian Executive Vice President - Global Technical Operations
Age: 55
Bio & Compensation  - Reuters
Douglas S. Ingram Esq. Executive Vice President and President, Europe, Africa, Middle East
Age: 50
Bio & Compensation  - Reuters
James F. Barlow Senior Vice President, Corporate Controller, Principal Accounting Officer
Age: 54
Bio & Compensation  - Reuters
David J. Endicott Corporate Vice President and President - Allergan Medical, Asia Pacific and Latin America
Age: 48
Bio & Compensation  - Reuters
Julian S. Gangolli Corporate Vice President and President, North America
Age: 55
Bio & Compensation  - Reuters